FHM2 patients with the G301R mutation resulting from a gene variant in the ATP1A2 gene have migraine comorbidity with epilepsy, coma, motor symptoms and psychiatric disorders such as depression and obsessive–compulsive disorder (OCD)31,32. This evidence concerns the gene ATP1A2 and psychiatric disorder.